Skip to main content
Caplight Logo









In vitro Plant-tech AB

In vitro Plant-tech AB

Private
SwedenHealthcare & Life Scienceshttps://invitroplanttech.se/

Last Round

Grant

Mar 26, 2013

Total Funding Raised

$109,000

Company Overview

In vitro Plant-tech AB is a biotechnology company that specializes in the development and production of botanical stem cell extracts and active ingredients for the cosmetic, pharmaceutical, and food industries using plant cell cultivation technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

plant cell cultivationbotanical extractsCDMOcontract development and manufacturingplant stem cellbiotech ingredientsclean beauty ingredientscallus extractssustainable raw materialscosmetic ingredientsnutraceutical ingredientslab-grown botanicalsbioprocessingcustom cell linesgreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

In vitro Plant-tech AB Comparables

Compare In vitro Plant-tech AB with similar companies based on industry and business-model similarity.

In vitro Plant-tech AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Naolys
81%
Ayana Bio
81%
Novella Innovative Technology
79%

In vitro Plant-tech AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 26, 2013
GrantMar 22, 2013

In vitro Plant-tech AB Investors

Notable investors and investment history

In vitro Plant-tech AB investors
InvestorRounds
VinnovaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2013

    $78K grant received from Vinnova.

  • Mar 22, 2013

    Secured $31K in grant funding.

In vitro Plant-tech AB Filings

Explore SEC and related filing metadata, where available.

In vitro Plant-tech AB filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about In vitro Plant-tech AB's valuation, stock price, and market status.

Is In vitro Plant-tech AB a public or private company?

In vitro Plant-tech AB is a private company.

What is the current stock price of In vitro Plant-tech AB?

In vitro Plant-tech AB is a private company with no public stock price. No recent secondary market data is available.

How much is In vitro Plant-tech AB worth (valuation)?

Valuation information for In vitro Plant-tech AB is not publicly available.

Can I buy In vitro Plant-tech AB stock?

In vitro Plant-tech AB shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was In vitro Plant-tech AB's last funding round?

In vitro Plant-tech AB's most recent funding round was Grant on March 26, 2013.

Who are the main investors in In vitro Plant-tech AB?

Key investors in In vitro Plant-tech AB include Vinnova.

Will In vitro Plant-tech AB IPO soon?

No public IPO plans have been announced for In vitro Plant-tech AB.

How can I track In vitro Plant-tech AB secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor In vitro Plant-tech AB's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSweden
Employee Range4
Year FoundedN/A
Last FundingMar 26, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?